Page 98 - Prostate News Today

Researchers from Barts Cancer Institute (BCI) at Queen Mary University of London, the Italian Institute for Genomic Medicine, and the University of Milan have identified a novel role for a cancer-causing gene in controlling an important genetic process that underpins genetic variation in prostate cancer.

Researchers at the University of East Anglia have made an important discovery about how prostate cancer may start to develop.

Minister of Health Jason Copping issued the following statement on Prostate Cancer Awareness Month:

Data from the Texas Cancer Registry shows prostate cancer is now the third-most prevalent form of cancer in McLennan County.

In a new study, researchers explored the genetic risk factors associated with various diseases to understand their impact on healthy life years.

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) will co-lead a new national center of excellence with the Royal College of Surgeons (RCS England) to strengthen NHS cancer services by looking at treatments and patient outcomes right across England and Wales.

For high-risk patients with prostate cancer, treatment with novel hormonal agents (NHAs) followed by surgery can reduce the risk of recurrent and progressive cancer, compared to initial treatment with surgery, suggests a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA).

The HSD3B1 gene could hold clues for predicting and treating endometrial cancer, according to a novel finding from the Cleveland Clinic's Lerner Research Institute.

EpiAxis Therapeutics and Canadas University Health Network have entered a collaboration to study a new epigenetics approach to prostate cancer treatment.

The drastic early-life changes in teens and young adults regarding diet, lifestyle, obesity, environment and the microbiome have led to a "genuine increase" in the incidence of early-onset forms of several cancers globally, a new Nature research has warned.